Nice OUtcomes for Referrals with Impulsivity, Self Harm and Eating Disorders: The NOURISHED Study

ISRCTN ISRCTN51304415
DOI https://doi.org/10.1186/ISRCTN51304415
Protocol serial number N/A
Sponsor Barnet Enfield and Haringey Mental Health Trust (UK)
Funder National Institute for Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB) programme (ref: PB PG 0408 15183)
Submission date
31/01/2011
Registration date
19/04/2011
Last edited
21/11/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Paul Robinson
Scientific

Research Department
St Ann's Hospital Block H
St Ann's Road
London
N15 3TH
United Kingdom

Phone +44 (0)20 8442 6503
Email drpaulrobinson@gmail.com

Study information

Primary study designInterventional
Study designMulticentre randomised single-blind controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA randomised controlled trial of mentalisation based therapy against specialist supportive clinical management in patients with both eating disorders and symptoms of borderline personality disorder
Study acronymNOURISHED
Study objectivesMentalisation based therapy is no more
1. Clinically effective
2. Cost effective
at reducing observer rated symptoms of eating disorder as measured by the global score of the Eating Disorders Examination Questionnaire (EDE-Q) in patients with combined eating and borderline personality disorder symptoms up to 18 months post-randomisation than specialist supportive clinical management.
Ethics approval(s)South East Research Ethics Committee, 14/12/2010, ref: 10/H1102/2
Health condition(s) or problem(s) studiedEating disorders/borderline personality disorder
Intervention1. Mentalisation Based Therapy (MBT): Intensive Outpatient program model for one year
2. Control treatment: Specialist Supportive Clinical Management (SSCM)

20 - 26 sessions over maximum one year for SSCM. Both groups receive 5 hours of dietetic advice in the year.
MBT participants receive weekly individual and group therapy for one year.
Intervention typeOther
Primary outcome measure(s)

Eating disorder symptoms will be measured 6-monthly using the global score of the Eating Disorder Examination (Time points: 0, 6, 12, 18 months)

Key secondary outcome measure(s)

1. Borderline Personality Disorder symptoms will be measured 6-monthly using the total score of the ZAN-BPD (Time points 0, 6, 12, 18 months)
2. The economic evaluation will examine the costs-effectiveness of Mentalization Based Therapy and Specialist Supportive Clinical Management including an analysis of incremental cost per QALY
3. Participant rated general psychiatric symptoms of Borderline Personality Disorder will be measured 6-monthly using the DASS-21 (Time points 0, 6, 12, 18 months)
4. Possible mediators of change in Borderline Personality Disorder symptoms include reflective function and object relations, measured by the Reflective Function Questionnaire, The Reading the Mind in the Eyes test and the Object Relations Inventory and personality factors (e.g. resilience, dysregulation, restriction) thought to be important in Eating Disorders (Time points 0, 6, 12, 18 months)

Completion date31/07/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration140
Key inclusion criteria1. Aged over 18 years, either sex
2. Eating disorder diagnosis
3. Borderline personality disorder (BPD) symptoms. The criteria for "BPD symptoms" are that the patient fulfils both behavioural criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), namely:
3.1. Impulsivity in at least two areas that are potentially self-damaging (e.g., spending, sexual behaviour, substance abuse, reckless driving, binge eating)
3.2. Recurrent suicidal behaviour, or self-mutilating behaviour
4. Able and willing to provide written informed consent
Key exclusion criteria1. Current psychosis
2. Current inpatient
3. Currently in psychological therapy
4. Received mentalisation-based treatment (MBT) less than 6 months prior to randomisation
5. Organic brain disease leading to significant cognitive impairment
6. Body mass index (BMI) less than 15 kg/m2 (normal range 19 - 25 kg/m2, anorexia nervosa less than 17.5 kg/m2)
Date of first enrolment01/04/2011
Date of final enrolment31/07/2013

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

St Ann's Hospital
London
N15 3TH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 17/11/2016 Yes No
Protocol article protocol 21/02/2014 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Study website Study website 11/11/2025 11/11/2025 No Yes

Editorial Notes

21/11/2016: Publication reference added.